Skip to main content

Feature article - Three ways the chemicals & materials industry can benefit from digital transformation

Dr Nina Kaun, product director, chemical industry solutions, at Elsevier, looks at how the Covid-19 pandemic could help to drive digitalisation

While many industries have taken advantage of technology developments in recent years, the chemicals and materials sector has been slower to digitalise. This attitude is now changing: 87% of chemicals and materials executives believe companies will ‘lose their edge’ or ‘face extinction’ unless they embrace digital transformation, including adopting more automation and applying artificial intelligence (AI) to some processes.

Feature article - How to start making hand sanitiser formula

Dr Russel Walters, freelance scientist at Kolabtree, shares his expertise on how to start manufacturing a hand sanitiser quickly, easily and compliantly

In order for a virus to infect a human host, the host needs to be exposed to a sufficient viral load, typically hundreds, thousands or tens of thousands of viral particles. Hand sanitisers dramatically reduce the viral load on the skin and therefore can reduce infections or perhaps infection severity.

Feature article – Covid-19 & a CDMO: A case study

Nicolas Biz, CDMO chief project officer, shows how Seqens rapidly developed production of a key material in the fight against Covid-19

Pending the availability of a vaccine, which will necessarily take time, the race against the clock is under way to identify and develop an anti-viral molecule effective against Covid-19. Research is taking place at an unprecedented speed, with more than 1,900 clinical trials listed worldwide since the start of the pandemic. Of these, 912 are in the process of patient testing.

CDMOs partnering in Covid-19 initiatives

Several of the world’s major pharmaceutical CDMOS have recently made announcements relating to their participation in projects to develop treatment for the Covid-19 virus. Many involve chloroquines, in anticipation of their large-scale use.

Feature Article – Covid-19 update: How the industry is responding

The news is entirely dominated by the coronavirus pandemic. Here, we summaries some of the key developments in the fine and speciality chemicals industry so far in April

Multiple companies are turning spare capacity over or building new capacity to supply hand sanitiser. Leading the way is Ineos, which had already built three such plants in the UK, France and Germany and has now announced plans to build a fourth at Etian, France, to serve hospitals in Paris, north-eastern France and Belgium.

Covi-19: Hand sanitiser effort continues

Chemical companies continue to invest in hand sanitiser in response to the Covid-19 pandemic. A large number of them are now producing in significant volumes.

Ineos, the largest European producer of the two key raw materials - isopropyl alcohol (IPA) and ethanol – has announced its intention to produce 1 million bottles of hand sanitiser/month from each of three newly built facilities in the UK, Germany and France.

Covid 19: Chemspec Europe delayed, FECC Congress cancelled

The Covid-19 pandemic, which had already led to the cancellation or postponement of multiple industry events scheduled for March and April, has now claimed two key events in Europe in late May.

Mack Brooks Exhibitions has postponed the 35th Chemspec Europe exhibition for fine and speciality chemicals from 27-28 May to 11-12 November. It will still take place at the Cologne Messe in Germany. This will be the first time it has even taken place out of its traditional slot in spring Managing director Nicola Hamann said:

Subscribe to covid-19

 

 

 

AMRI banner advert